Metropolitan Life Insurance Company (MetLife)’s Cytosorbents Corp CTSO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,670	Closed	-$94.8K	–	2792
2021 Q3	$94.8K	Buy	+11,670	New	+$94.8K	﹤0.01%	2553
2021 Q2	–	Sell	-9,062	Closed	-$78.7K	–	2748
2021 Q1	$78.7K	Sell	9,062 -1,423	-14%	-$13.6K	﹤0.01%	2480
2020 Q4	$83.6K	Hold	10,485	–	–	﹤0.01%	2419
2020 Q3	$83.6K	Hold	10,485	–	–	﹤0.01%	2316
2020 Q2	$104K	Buy	10,485 +8,112	+342%	+$74.5K	﹤0.01%	2238
2020 Q1	$18.3K	Buy	+2,373	New	+$12K	﹤0.01%	2447
2019 Q3	–	Sell	-8,477	Closed	-$56K	–	2584
2019 Q2	$56K	Hold	8,477	–	–	﹤0.01%	2492
2019 Q1	$64.2K	Sell	8,477 -1,965	-19%	-$15.3K	﹤0.01%	2492
2018 Q4	$84.4K	Hold	10,442	–	–	﹤0.01%	2373
2018 Q3	$135K	Hold	10,442	–	–	﹤0.01%	2271
2018 Q2	$119K	Buy	+10,442	New	+$98.9K	﹤0.01%	2231

Other funds holding CTSO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CTSO Position: Q4 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Cytosorbents Corp (CTSO) in Q4 2021, closing a stake of 11,670 shares — an estimated $94.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CTSO in Q2 2018 and held it in 11 quarters. The position peaked at $135K in Q3 2018. 91 funds tracked by Wall St. Rank hold CTSO as of Q4 2021.

Metropolitan Life Insurance Company (MetLife) reported no remaining Cytosorbents Corp position as of Q4 2021 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 11,670 Cytosorbents Corp shares in Q4 2021, an estimated $94.8K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Cytosorbents Corp in Q2 2018 and held it in 11 quarters.
Metropolitan Life Insurance Company (MetLife)'s Cytosorbents Corp position peaked at $135K in Q3 2018.
91 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.